ABSTRACT
Choroidal osteoma is an unusual form of intraocular calcification seen in otherwise healthy eyes. It is a benign idiopathic osseous tumor of the choroid, typically seen in young females. Choroidal neovascular membrane (CNVM) is a complication seen in one-third of these patients and carries a poor visual outcome. We report a case of a 25-year-old hyperthyroid female with choroidal osteoma and subfoveal CNVM in her left eye which was successfully treated using low-fluence photodynamic therapy (PDT) with verteporfin followed by a single injection of intravitreal ranibizumab.
Subject(s)
Adult , ANTIBODIES, MONOCLONAL, HUMANIZED ADMINISTRATION & , Bone Neoplasms/complications , Bone Neoplasms/diagnosis , Bone Neoplasms/drug therapy , Choroid Neoplasms/complications , Choroid Neoplasms/diagnosis , Choroid Neoplasms/drug therapy , Choroidal Neovascularization/diagnosis , Choroidal Neovascularization/drug therapy , Choroidal Neovascularization/etiology , Diagnosis, Differential , Female , Follow-Up Studies , Humans , Intravitreal Injections , Microscopy, Acoustic , Osteoma/complications , Osteoma/diagnosis , Osteoma/drug therapy , Photochemotherapy/methods , Tomography, Optical Coherence , Visual AcuityABSTRACT
Angioid streaks also called Knapp striae are small breaks in the Bruch's membrane and have been reported with a host of systemic diseases. Rupture of streaks or development of secondary choroidal neovascular membrane (CNVM) carries a dismal visual prognosis. We report the successful treatment of CNVM secondary to Paget's disease using low fluence photodynamic therapy (PDT) and intravitreal ranibizumab.
Subject(s)
Angiogenesis Inhibitors/administration & dosage , Angioid Streaks/complications , Angioid Streaks/diagnosis , Angioid Streaks/etiology , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal, Humanized , Choroidal Neovascularization/diagnosis , Choroidal Neovascularization/drug therapy , Choroidal Neovascularization/etiology , Drug Therapy, Combination , Fluorescein Angiography , Fundus Oculi , Humans , Intravitreal Injections , Male , Middle Aged , Osteitis Deformans/complications , Osteitis Deformans/pathology , Photochemotherapy/methods , Treatment OutcomeABSTRACT
We report a case of branch retinal artery occlusion (BRAO) in a healthy young girl. An eight-year-old girl presented with sudden loss of vision in her left eye. She had a pale retina with macular edema consistent with extensive BRAO. A thorough workup was performed to determine any etiologic factor. All test results were within normal limits. Her visual acuity improved from finger counting to 20/40 over two weeks, on immediate treatment with intravenous steroids (methyl prednisolone). This case suggests that BRAO can occur in healthy children without any detectable systemic or ocular disorders and a dramatic improvement may be achieved with prompt treatment with intravenous steroids.
Subject(s)
Child , Female , Humans , Retinal Artery Occlusion/diagnosis , Retinal Artery Occlusion/pathology , Retinal Artery Occlusion/therapyABSTRACT
PURPOSE: To analyse the clinical characteristics and treatment outcome of zone 1 Fulminate type of Retinopathy of Prematurity (ROP) and compare it to Conventional ROP. METHODS: Preterm infants from two neonatal intensive care units (NICU) born between July 2002 and November 2003 were screened for ROP. Cases with Conventional ROP were classified according to the International Classification of Retinopathy of Prematurity (ICROP) while that of Fulminate ROP according to Shapiro's classification. Threshold disease was kept the cut off for treatment for Conventional ROP and stage 3A for Fulminate ROP. RESULTS: Of the 54 cases that had treatable ROP, 36 (66.67%) had Fulminate type. The mean gestational age and birth weight was higher in Fulminate ROP compared to Conventional disease (31.75 weeks and 1554 gms vs 31 weeks 1387 gms) whereas the mean postnatal age at laser was lower (4.62 weeks vs 6.3 weeks). The average number of laser spots given was 3036.6 for Fulminate disease. CONCLUSION: Fulminate ROP had an atypical morphology which was difficult to classify according to ICROP classification and we would like to lay stress upon the importance of screening of premature infants from the age of 4 weeks and to start treatment immediately once Fulminate ROP has been diagnosed.